Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment.

Autor: Pawłowska, A.1 (AUTHOR) annpawlows@gmail.com, Suszczyk, D.1 (AUTHOR), Okła, K.1 (AUTHOR), Barczyński, B.1 (AUTHOR), Kotarski, J.1 (AUTHOR), Wertel, I.1 (AUTHOR)
Zdroj: Clinical & Experimental Immunology. Mar2019, Vol. 195 Issue 3, p334-344. 11p. 2 Diagrams, 2 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje